With respect to the affected TGF-ß pathway, a new trial was recently launched: “Addition of TGF-β and PDL-1 Inhibition to Definitive Chemoradiation in Esophageal Squamous Cell Carcinoma (TAPESTRY)” (NCT04595149). Here, CD274 is linked to esophageal squamous cell carcinoma.